{"type":"rich","title":"Pharmacist Panel Discussion \u2013 Perspectives on Section N, Understanding Medication Indication of Use Versus Diagnosis","version":"1.0","provider_name":"Blubrry","provider_url":"https://blubrry.com","author_name":"LTC NAC Chat","html":"<iframe src=\"https://player.blubrry.com/?podcast_id=127885993\" title=\"Blubrry Podcast Player\" scrolling=\"no\" width=\"100%\" height=\"230\" frameborder=\"0\"></iframe>","height":"230","description":"In this podcast, Amy Stewart, MSN, RN, DNS-MT, QCP-MT, RAC-MT, RAC-MTA, chief nursing officer for AAPACN, Marti Wdowicki, PharmD, director of clinical operations for PharMerica, and Jeff Herr, PharmD, manager of clinical operations in the West for PharMer","thumbnail_url":"https://assets.blubrry.com/coverart/160/569802-1782123194.jpg"}